Pharmacological manipulation of the ductus arteriosus.
Open Access
- 1 September 1986
- journal article
- research article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 61 (9) , 827-829
- https://doi.org/10.1136/adc.61.9.827
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Early administration of indomethacin to preterm infants.Archives of Disease in Childhood, 1986
- Evaluation of oral and low dose intravenous prostaglandin E2 in management of ductus dependent congenital heart disease.Archives of Disease in Childhood, 1985
- Clinical course to 1 year of age in premature infants with patent ductus arteriosus: Results of a multicenter randomized trial of indomethacinThe Journal of Pediatrics, 1984
- Effects of indomethacin in premature infants with patent ductus arteriosus: Results of a national collaborative studyThe Journal of Pediatrics, 1983
- Prostaglandin E1 infants with ductus arteriosus-dependent congenital heart disease.Circulation, 1981
- Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.Circulation, 1981
- Dilatation of the ductus arteriosus by prostaglandin E1 in aortic arch abnormalities.Circulation, 1979
- Palliation of cyanotic congenital heart disease in infancy with E-type prostaglandins.Circulation, 1977
- E-type prostaglandins: a new emergency therapy for certain cyanotic congenital heart malformations.Circulation, 1976
- MEDICAL MANIPULATION OF THE DUCTUS ARTERIOSUSThe Lancet, 1975